The development of BRPF1 degraders as a potential treatment for AML

Time: 12:00 pm
day: Day 2 AM - Stream A


  • The key areas for the development and designing of PROTAC degraders
  • The rationale for degradation of BRPF1 in AML and beyond
  • The biological characterisation of newly synthesised compounds